 Part 1 will find the maximum tolerated dose MTDmaximum administered dose MAD, confirm the dose, and find the recommended Phase 2 dose RP2D for pembrolizumab therapy. Part 2 will further evaluate the safety and efficacy at the pediatric RP2D. 